Huang Tianyi, Poole Elizabeth M, Okereke Olivia I, Kubzansky Laura D, Eliassen A Heather, Sood Anil K, Wang Molin, Tworoger Shelley S
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Gynecol Oncol. 2015 Dec;139(3):481-6. doi: 10.1016/j.ygyno.2015.10.004. Epub 2015 Oct 9.
While emerging evidence supports a possible link between depression and ovarian cancer progression, no prospective studies have explored the association with ovarian cancer risk.
We prospectively followed 77,451 women from the Nurses' Health Study (1992-2010) and 106,452 women from the Nurses' Health Study II (1993-2011). Depression was defined as having one or more of the following: a 5-item Mental Health Index (MHI-5) score≤52, antidepressant use, or physician-diagnosed depression. Multivariable-adjusted Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between depression and incident ovarian cancer.
We documented 698 incident cases of epithelial ovarian cancer during follow-up. In multivariable analyses, depression assessed 2-4years before cancer diagnosis was associated with a modestly higher incidence of ovarian cancer (HR=1.30, 95% CI 1.05-1.60). Compared to women with persistent negative depression status, the adjusted HRs were 1.34 (95% CI 1.01-1.76) for women with persistent positive depression status and 1.28 (95% CI 0.88-1.85) for women with worsening depression status over follow-up. The association did not appear to vary by ovarian cancer risk factors or tumor characteristics.
Our findings suggest that depression may be associated with a modestly increased risk of ovarian cancer. Given the relatively high prevalence of depression in women, future work in larger prospective human studies is needed to confirm our results.
虽然新出现的证据支持抑郁症与卵巢癌进展之间可能存在联系,但尚无前瞻性研究探讨其与卵巢癌风险的关联。
我们对来自护士健康研究(1992 - 2010年)的77451名女性和护士健康研究II(1993 - 2011年)的106452名女性进行了前瞻性随访。抑郁症的定义为具备以下一项或多项:5项心理健康指数(MHI - 5)得分≤52、使用抗抑郁药或经医生诊断为抑郁症。采用多变量调整的Cox比例风险模型来估计抑郁症与卵巢癌发病之间关联的风险比(HRs)和95%置信区间(CIs)。
在随访期间,我们记录了698例上皮性卵巢癌发病病例。在多变量分析中,癌症诊断前2 - 4年评估的抑郁症与卵巢癌发病率适度升高相关(HR = 1.30,95% CI 1.05 - 1.60)。与持续处于阴性抑郁状态的女性相比,持续处于阳性抑郁状态的女性调整后HR为1.34(95% CI 1.01 - 1.76),随访期间抑郁状态恶化的女性调整后HR为1.28(95% CI 0.88 - 1.85)。这种关联似乎不因卵巢癌风险因素或肿瘤特征而有所不同。
我们的研究结果表明,抑郁症可能与卵巢癌风险适度增加有关。鉴于女性中抑郁症的患病率相对较高,未来需要在更大规模的前瞻性人体研究中开展工作以证实我们的结果。